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Abstract
Background: CDK11
p58 is a mitotic protein kinase, which has been shown to be required for different mitotic events such as
centrosome maturation, chromatid cohesion and cytokinesis.
Methodology/Principal Findings: In addition to these previously described roles, our study shows that CDK11
p58 inhibition
induces a failure in the centriole duplication process in different human cell lines. We propose that this effect is mediated by
the defective centrosomal recruitment of proteins at the onset of mitosis. Indeed, Plk4 protein kinase and the centrosomal
protein Cep192, which are key components of the centriole duplication machinery, showed reduced levels at centrosomes
of mitotic CDK11-depleted cells. CDK11
p58, which accumulates only in the vicinity of mitotic centrosomes, directly interacts
with the centriole-associated protein kinase Plk4 that regulates centriole number in cells. In addition, we show that centriole
from CDK11 defective cells are not able to be over duplicated following Plk4 overexpression.
Conclusion/Significance: We thus propose that CDK11 is required for centriole duplication by two non-mutually-exclusive
mechanisms. On one hand, the observed duplication defect could be caused indirectly by a failure of the centrosome to
fully maturate during mitosis. On the other hand, CDK11
p58 could also directly regulate key centriole components such as
Plk4 during mitosis to trigger essential mitotic centriole modifications, required for centriole duplication during subsequent
interphase.
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Introduction
The centrosome of somatic cells is the main microtubule
organising center [1]. It is required to organise the cytoplasmic
microtubule network during interphase and the mitotic spindle
during mitosis. This organelle consists of two centrioles embedded
in an amorphous pericentriolar material (PCM). In proliferating
cells before division, the centrosome needs to be duplicated
precisely once so that the mitotic cell harbours two centrosomes,
each comprising two centrioles. These two centrosomes will be
used to nucleate the microtubules required to assemble the mitotic
bipolar spindle during mitosis [2]. The centrosome duplication
cycle is divided into several key steps. First, during mitosis, the two
paired-centrioles inherited by the daughter cell lose their
orthogonal configuration, a process called disengagement. Then,
procentrioles (daughter centrioles) nucleate in G1/S phase at an
orthogonal angle next to each mother centriole. The two newly
synthesised centrioles elongate during the S and G2 phases. In late
G2, as cells prepare for mitosis, centrosomes increase in size and
recruit additional PCM to enhance their ability to nucleate
microtubules. This process is referred to as centrosome matura-
tion. At the end of the G2 phase, the two newly duplicated
centrosomes separate to organise a bipolar mitotic spindle,
enabling each daughter cell to inherit one centrosome after cell
division.
In contrast to normal cells, tumour cells frequently show
centrosome number defects that are thought to be the conse-
quence of abnormal regulation of the centriole duplication
machinery. Thus, the restriction to a single round of centriole
duplication per cell division cycle contributes to the prevention of
aberrant centrosome numbers, multipolar spindles and chromo-
somal instability [3,4].
Several proteins are critical for the canonical centriole assembly.
Based on genome-wide RNAi and genetic screens in C. elegans,a
molecular hierarchy for the recruitment of five essential proteins
for centriole assembly has been established. SPD-2 is necessary to
recruit ZYG-1 at the centriole. Then, both proteins in turn recruit
SAS-5 and SAS-6, followed by SAS-4 [5,6,7]. Most of these
proteins have conserved roles in centriole duplication in other
systems. Cep192, the human homolog of C. elegans SPD-2 protein,
is a pericentriolar protein required for both centriole duplication
and centrosome maturation [8,9]. Plk4, related to C. elegans ZYG-
PLoS ONE | www.plosone.org 1 January 2011 | Volume 6 | Issue 1 | e14600Centrosome Biogenesis
PLoS ONE | www.plosone.org 2 January 2011 | Volume 6 | Issue 1 | e146001, as well as CPAP and HsSAS-6, human homologs of C. elegans
SAS-4 and SAS-6, have been identified as key regulators of
centriole duplication [8,10,11,12]. For example, overexpression of
Plk4 leads to centriole amplification; conversely, mutations or
inhibition of the DmSAK/PLK4 gene dramatically impairs centriole
duplication [10,11]. Of these proteins, Plk4 is the only enzyme. It
is a short-lived protein kinase that localises at centrioles
throughout the cell cycle. Its degradation and activity are tightly
regulated during the cell cycle, these two processes being crucial
for the centriole biogenesis process [13,14].
SAS-6, Chk2, CDC25c and Hand1 remain the only identified
substrate of Plk4/SAK/ZYG-1 [15,16,17,18,19,20]. The physio-
logical relevance of CDC25c and Chk2 phosphorylation events by
Plk4 is unknown. SAS-6 phosphorylation by ZYG-1 in C. elegans
triggers its targeting to the newborn centriole. The Plk4-mediated
phosphorylation of the Hand1 transcription factor inhibits its
sequestration in the nucleolus. Hand1 is then released in the
nucleus where it activates the transcription of genes required for
cell differentiation. Interestingly, a growing list of studies in
different models shows that Plk4 centrosomal levels and activity
are maximal during mitosis, suggesting the kinase also plays a key
role during mitosis, possibly to licence the centriole for subsequent
duplication in S phase. However, this possible role remains
speculative and difficult to challenge experimentally [14,21].
Cyclin-dependant kinase 11 (CDK11) mRNA produces a
110 kDa isoform protein expressed throughout the cell cycle and
a 58 kDa isoform protein which is specifically translated from an
internal ribosomal entry site sequence during G2/M [22]. The
small isoform has been shown to be an essential regulator of
mitosis. Indeed, CDK11
p58 is required for centrosome maturation,
bipolar spindle assembly, maintenance of sister chromatid
cohesion and cytokinesis [23,24,25].
In this article we describe a new role for CDK11
p58 in the
duplication of centrioles. Our data reveal that CDK11 is necessary
to ensure proper centriole duplication. Furthermore, we identify
Plk4 as a novel partner of CDK11
p58 and show that CDK11
p58
depletion impairs the proper recruitment of Plk4 to mitotic
centrosomes.
Results
We have shown previously that CDK11
p58 is required for
centrosome maturation (Petretti et al., 2006). A growing list of
studies reports that failure to properly orchestrate centrosome
maturation can trigger centriole duplication defects. As an
example, Cep192 is a major regulator of both centrosome
maturation and centriole duplication in C. elegans and in
mammalian cells [7,8,26]. These data prompted us to investigate
whether CDK11
p58 was also required for centriole duplication. To
do so, we first looked at the effects of a three-day siRNA-mediated
depletion of CDK11 on centriole numbers in asynchronously
growing mitotic cells (Figure 1 A). HeLa cells stably expressing
GFP-centrin protein [27] were transfected with control or CDK11
specific siRNAs [24] and centrioles were quantified on mitotic
figures after fixation of the cells (Figure 1 D). As expected, 90.6%
of control metaphase cells showed four centrioles with two centrin
dots at each pole of the mitotic spindle (Figure 1 and Table S1). By
contrast, after depletion of CDK11, as shown previously, only
37.9% of the spindles were bipolar [24]). Amongst these, only
10.8% of the cells looked normal with two centrin dots at each
pole whereas 26.9% of the cells showed spindles with less than two
centrioles at one pole. The remaining mitotic cells appeared to
form very short or monopolar spindles (54.4%) and all of them
showed a reduction in centriole numbers (i.e. less than four
centrioles in total). Plk4 RNAi treatment, used as a positive control
(Figure 1 C, D and Table S1), yielded highly similar phenotypes
with only 14.4% of the cells showing bipolar mitotic spindles with
four centrioles, two at each pole. The vast majority of the mitotic
cells displayed monopolar and disorganised spindles and showed
less than four centrioles. Interestingly, co-depletion of Plk4 and
CDK11
p58 proteins resulted in an 8- to 9-fold decrease of the
number of cells showing bipolar spindles with four centrioles
(10.8% and 14.4% respectively in CDK11- and Plk4-depleted cells
vs. 1.5% in co-depleted cells). We observed a dramatic increase in
the number of cells with only one centriole when both CDK11
and Plk4 were knocked down (13,9% and 17.8% respectively in
CDK11 and Plk4-depleted cells vs. 67.8% in co-depleted cells)
(Figure 1 C, D and Table S1).
Most of the proteins required for centrosome duplication
localise to this structure. To localise CDK11
p58 protein kinase
within the cell, we decided to generate a HeLa ‘‘Tet-ON’’ cell line
which allows the temporally controlled expression of Myc-tagged
CDK11
p58 (Figure S1). The Myc antibody readily recognised one
protein of the expected size in the above cell line induced to
express the transgenic protein (data not shown) and also in
transiently transfected cells (Figure 2 A) but did not reveal any
specific bands in non-induced or control cells validating our Tet-
inducible expression system. Immunofluorescence experiments
were performed after a very short period of induction (1 to
2 hours), when the protein was expressed at low level. We found
that Myc-tagged CDK11
p58 protein kinase was cytoplasmic in
interphase (Figure S1 A and B). During early prophase, CDK11
p58
was principally detected around the separating centrosome and on
newly nucleated microtubules. In metaphase cells, the protein
localised in the vicinity of the centrosome, and decorated spindle
microtubules (Figure S1 and C). Following depolymerisation of
microtubules by cold treatment, no obvious localisation of
CDK11
p58 was observed at the mitotic centrosomes suggesting
that the centrosomal localisation is microtubule dependent (data
not shown). CDK11
p58 persisted on microtubules emanating from
the poles and on the central spindle during telophase and was
finally enriched on both sides of the midbody during cytokinesis
(Figure S1). Interestingly enough, longer induction to express high
levels of Myc-tagged protein increased the cytoplasmic pool
resulting in the masking of the signal on mitotic microtubules. This
latter result might suggest the existence of a limited number of
CDK11
p58-binding sites on the mitotic spindle.
Figure 1. CDK11
p58 depletion leads to a reduction in centriole number in mitotic HeLa cells. Mitotic HeLa cells stably expressing a GFP-
tagged centrin were subjected to control or CDK11 RNAi and analysed after 72 hours. A) Western blots showing CDK11
p110 and CDK11
p58 (with 10
and 600 seconds exposure times respectively) and actin protein levels are shown. The positions of CDK11
p110 and CDK11
p58 are indicated. B) Mitotic
cells stained for DNA (blue) and centrin (red) following control or CDK11 RNAi. Some of the observed defects are shown here. The insets show a 36
magnification view of the centriole region in monochrome. The treatment is displayed at the bottom of each panel. Scale bar is 5mm. C) Quantitative
analysis of the centriole distribution following control, CDK11, Plk4 or double RNAi in mitotic cells. See the reduced number of centrioles following
CDK11 RNAi (also shown in Table S1). D) Example of the mitotic figures observed in control, CDK11, Plk4 and double (CDK11 and Plk4) siRNA–
transfected cells. See also detailed analysed in Table S1. Centrioles are green, microtubules are red and chromosomes are blue. The insets show a 36
magnification view of the centriole region in monochrome (indicated by a white triangle in the merge panels). Bar is 5mm.
doi:10.1371/journal.pone.0014600.g001
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duplication leads to a decrease of the centriole number. By
contrast, only a very low number of these molecules, including the
Plk4 protein kinase, triggers centriole amplification via their
overexpression (reviewed in Bettancourt 2009). To continue the
investigation on the function of CDK11
p58 in centriole biogenesis,
we decided to check whether the overexpression of a Myc-tagged
wild-type CDK11
p58 protein, a kinase-dead variant
(CDK11
p58DN) and Plk4 (as a positive control) could modify
centriole duplication (see Figure 2 A). CDK11
p58, CDK11
p58DN,
Plk4 were transiently expressed in HeLa cells stably expressing the
GFP-centrin protein. A day after transfection, aphidicolin was
added for 48 hours on these cells to arrest them in S phase
(Figure 2 B). Cells were then immuno-stained with Myc antibody
and the centrioles of Myc-positive arrested cells were counted
(Figure 2 C). As expected, the vast majority (71%) of control cells
had duplicated their centrioles during this arrest and thus
exhibited four centrioles per cell (two pairs of two closely-linked
centrioles). When compared to controls, cells overexpressing
CDK11
p58 did not show significant differences in their centriole
numbers (,70%, Figure 2 D). By contrast, the overexpression of
the catalytically inactive CDK11
p58DN caused a decrease in the
number of cells with four centrioles. Indeed, only 38% of these
cells contained four centrioles, while 58% failed to duplicate their
centrioles, resulting in the presence of cells with either two or three
centrioles (Figure 2 C and D). In a parallel assay, the ability of
these cells to amplify their centrioles after Plk4 overexpression was
assessed. As published before [11], most of the Myc-Plk4 positive
cells amplified their centrioles (Figure 2 C, right panels, and D).
Therefore, the dead variant of CDK11
p58 has the ability to inhibit
centriole duplication, suggesting it behaves as a dominant negative
toward the endogeneous active kinase to prevent centriole
duplication. CDK11
p58 kinase activity would thus be required
for this process.
In order to further corroborate our observation that CDK11
p58
is required for centriole duplication, we used a centriole
overduplication assay in U2OS cells. In this cell line, a prolonged
S phase arrest induces multiple rounds of centriole duplication. As
a consequence, inhibition of proteins required for centriole
duplication leads to a decrease in the number of cells with more
than two centrosomes (Habedanck, 2005). U2OS cells were
transfected with control, Plk4 (as a positive control) or CDK11
siRNA for 24 hours before being arrested during S phase with
aphidicolin for 48 hours (Figure S2 A). Cells were fixed and
centrosomes were stained with anti-c-tubulin antibodies (Figure S2
B). In control S-phase arrested cells, 29.061.4% of the cells
showed more than two centrosomes (Figure S2 C). A noticeable
decrease was observed in Plk4 and CDK11-depleted cells, with a
percentage of cells displaying more than two centrosomes of
9.062.1% and 11.961.7% respectively, indicating a ,3-fold
inhibition of the spontaneous centriole over duplication process
observed in U2OS control cells. This latter result further highlights
the requirement of CDK11
p58 in the centriole duplication process.
Previous experiments showed that CDK11-depletion dimin-
ished c-tubulin and Plk1 recruitment at the centrosomes during
centrosome maturation [24]. Interestingly, Plk1 depletion abol-
ishes Cep192 recruitment at centrosomes [8,26]. We first decided
to analyse the levels of Cep192 protein at mitotic centrosomes
(containing 2 centrioles) following control or CDK11 RNAi (Figure
S3 A). Quantification of the signal revealed that centrosomal
Cep192 was reduced by 3-fold at centrioles in mitotic CDK11-
depleted cells (Figure S3 B) but the interphase centrosome level
was unchanged (data not shown). SPD-2, the worm counterpart of
Cep192 is also required for ZYG-1, the related orthologue of Plk4,
to be recruited at centrosomes [5,7]. Plk4 is a centriole-associated
protein kinase. The protein kinase levels in the whole cell and at
the centrosome are elevated during mitosis, by contrast to
interphase. We next monitored whether CDK11
p58 was also
implicated in Plk4 recruitment to the centrosomes in mitosis.
Control and CDK11-RNAi treated cells were stained with Plk4,
centrosome (Figure 3 A) or centriole probes antibodies (Figure 3
B). Strikingly, CDK11 depletion also impaired Plk4 accumulation
at mitotic centrosomes (Figure 3 A–C) whereas staining of Plk4 at
centrosomes in interphasic cells was not reduced (Figure 3 D and
E). In parallel, we also checked whether the Plk4 protein was stable
in CDK11 knock down cells to rule out the possibility that the low
amount of centrosomal Plk4 after CDK11 RNAi was caused by an
overall Plk4 protein disappearance. As endogenous Plk4 protein
cannot be detected by Western blot, we examined the stability of
full length Plk4 or a shorter Plk4 fragment also containing its
phosphodegron motif [13]. For this purpose, we co-transfected
control or CDK11 siRNA together with the Myc-tagged Plk4
constructs and examined by Western blot exogenous Plk4 protein
levels. Exogenous Plk4 proteins were very unstable and difficult to
detect in the control cells 48 h following RNAi. However, we
found that Myc-Plk4 proteins were more stable in CDK11 knock
down cells (Figure 3 F), suggesting that more Plk4 protein was
present in this case but not targeted to the mitotic centrosomes.
Taken together, the above results point out that CDK11
p58 is
essential for the correct recruitment of multiple centrosomal
proteins including Plk1 and c-tubulin, but also Cep192 and
Plk4.
To date, very few proteins have been found to associate with
Plk4. We further tempted to investigate whether CDK11
p58 could
physically interact with this master regulator of centriole
duplication. As endogenous CDK11
p58 and Plk4 proteins are
difficult to detect in cell lysates, we decided to co-express these two
proteins with different tags in COS-7 cells and we carried out
immunoprecipitation experiments (Figure 4 A, B and C). We were
able to detect Myc-Plk4 in GFP-CDK11
p58 pull down (IP GFP,
Figure 4 B) and GFP-CDK11
p58 was reciprocally found in Myc-
Plk4 pull-down (IP MYC, Figure 4 B). We then performed the
same experiment using truncated Myc-Plk4 proteins containing
either the N-terminal or the C-terminal end of the protein (Figure 4
C). Interestingly enough, the interaction was only observed
between CDK11
p58 and the N-terminal domain of Plk4 (NT),
Figure 2. Kinase-dead CDK11
p58D/N but not wild-type CDK11
p58 overexpression leads to a centriole duplication failure in S-phase
arrested HeLa cells. A) Expression of Myc-CDK11
p58 and Myc-CDK11
p58D/N (left) or Myc-Plk4 proteins following transfection of the appropriate
constructs. A Myc and an actin (as a loading control) Western blotting are shown. B) HeLa cells stably expressing GFP-tagged centrin were transfected
with either active (CDK11
p58) or inactive (CDK11
p58DN) CDK11
p58 expression constructs. A positive control was also performed using Myc-Plk4. After
24 hours (duration of one cell cycle), the cells were arrested in S phase by aphidicolin treatment for 24 hours and the centrioles were counted after 48
more hours. C) The transfected cells expressing Myc-tagged proteins were visualised using an anti-Myc antibody (red). DNA is blue. The centriole
(green), indicated by arrows, (also displayed in monochrome in the lower panels) were counted in control or transfected cells. In cells expressing
CDK11
p58 as well as in control cells, the vast majority of the cells (,70%) displayed four centrioles. This percentage dropped to 38.2% when
CDK11
p58DN was expressed. Note that more than 80% of the Plk4 over expressing cells showed centriole amplification. Scale bar is 10mm. D) Graph
(6SD) showing the percentage of cells with ,4 centrioles (blue), 4 (green) or .4 (orange).
doi:10.1371/journal.pone.0014600.g002
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gron motif required for protein stability [13]. We didn’t find any
interaction of CDK11
p58 with the Plk4 C-terminal fragment
containing the polo box (Figure 4 C). To verify that Plk4 and
CDK11
p58 were able to interact directly, we performed an in vitro
pull down assay using Maltose-Binding Protein (MBP)-tagged
CDK11
p58 immobilised on an amylose column and a recombinant
V5-tagged full length Plk4 (See Method section and Figure 4 D).
Although the immobilised CDK11
p58 protein kinase was inactive
(not able to phosphorylate any of the in vitro CDK kinase substrates
like histone H1, MBP or casein), it was able to interact with Plk4 in
vitro, revealing a direct interaction between the two proteins
(Figure 4 D).
As CDK11
p58 and Plk4 are protein kinases that physically
interact, it was tempting to speculate that one could be the
substrate of the other. Unfortunately, soluble recombinant
CDK11
p58 is inactive so the CDK11
p58 kinase assay on Plk4
was not possible. However, we were able to check that active Plk4
could not phosphorylate a recombinant MPB-tagged CDK11
p58
(Figure S4), since after incubation of these proteins together we
couldn’t observe any phosphorylated band, whereas Plk4 was able
to phosphorylate b casein (positive control). This result suggests
that CDK11
p58 is not a substrate of Plk4.
Our study reveals that the mitotic specific CDK11
p58 is able to
associate with Plk4 during mitosis and is required to target the Plk4
protein kinase to the centrosome in mitosis. In a last experiment,
we decided to check whether mitotic centrioles that had passed
mitosis with decreased CDK11 activity were able to respond to
high Plk4 activity in the following interphase by amplifying their
centrioles. For this purpose, we performed CDK11 RNAi on HeLa
cells for two days (to allow CDK11 depletion) and we
overexpressed Myc-Plk4 by transient transfection to trigger
centriole amplification in the presence of aphidicolin (Figure 5
A). As expected in S-phase arrested control cells, a majority of the
cells (75.9610.4%) displayed 4 centrioles whereas only
52.1610.0% of the CDK11–depleted cells exhibited this pheno-
type (Figure 5 C). In this population, we also observed a strong
increase of cells with less than 4 centrioles (43.8615.6%)
compared to controls (13.864.9%). When we overexpressed
Myc-Plk4 in control siRNA treated cells, we observed a strong
increase in the number of cells showing a severe centriole
amplification (52.169.8%) whereas a limited percentage of
CDK11 knock down cells overexpressing Plk4 were able to
amplify their centrioles (16.760.4%). However, in these inter-
phase-arrested cells, a strong recruitment of Plk4 could be
observed (Figure 5 B, right panel). Thus, overexpressed Plk4
protein kinase is strongly recruited to interphase centrioles but
cannot induce their amplification following CDK11 RNAi.
Discussion
Our study reveals for the first time a role for CDK11
p58 during
the centriole duplication process, and our data suggest that the
protein acts in helping the recruitment of master regulators of this
process at centrosomes during mitosis. The kinase activity of
CDK11
p58 seems necessary for its function in the centriole
duplication process, since the overexpression of the kinase-dead
variant phenocopies CDK11 RNAi and inhibits centriole
duplication.
In agreement with such a mitotic role, the CDK11
p58 isoform is
of low abundance and generated through the use of an internal
ribosome entry site on the CDK11 mRNA regulated in a mitosis
specific manner, leading to this isoform being only present in
mitosis [22].
To explain this new function of CDK11
p58, two hypotheses can
be made (see model Figure S5). First, we have shown previously
that CDK11
p58 is necessary to recruit Plk1 and c-tubulin during
centrosome maturation, which in turn can affect the recruitment
of Cep192 and thus possibly Plk4 as well [24]. Indeed, Haren et al.
have described that Cep192 recruitment was abolished in Plk1-
depleted cells [26]. Moreover, the Cep192 worm counterpart,
SPD-2, is required for ZYG-1, the related orthologue of Plk4, to
be recruited at centrosomes [5,7]. Furthermore, Plk1 and separase
have been recently involved in the licensing mechanism [28,29].
The ‘‘licensing model’’ suggests that centrioles (like DNA) are
marked during mitosis to allow their duplication in the following
interphase [2,14,30]. In agreement with this ‘‘licensing’’ hypoth-
esis, electron microscopy studies of amplifying centrioles revealed
that only the mother centrioles (generated from previous cell cycle)
can be used as a template to generate daughter centrioles [6]. After
down regulation of Plk1, centrioles fail to disengage and
subsequently centriole duplication is blocked [28,29]. These last
results demonstrate that a complex network of proteins might be
necessary to trigger the centrosome biogenesis and that a strong
correlation exists between maturation of centrosomes during
mitosis and their duplication in interphase (Figure S5).
The second hypothesis would be that CDK11
p58 might also
mediate its role via its direct interaction with Plk4. However,
CDK11
p58 associates with mitotic microtubules but is not localised
at the centrioles itself and was not, so far, characterised as a core
component of purified human or Drosophila centrosomes [31,32].
This might suggest that the interaction with Plk4 occurs mostly in
the cytoplasm of the cell or on spindle microtubules. Interestingly,
the level of Plk4 protein kinase is tightly regulated throughout the
cell cycle by ubiquitin-mediated proteolysis via SCF
Slimb in
Drosophila [13,14] and human cell lines [33]. Plk4 degradation
and maintenance of appropriate protein levels in the cell requires
phosphorylation of a phosphodegron motif present in the N-
Figure 3. CDK11 depleted cells show diminished recruitment of the Plk4 protein at the mitotic centrosomes. A) HeLa cells were
transfected with control or CDK11 siRNAs and stained for Plk4 (red and right panels in monochrome) and c tubulin (green and middle panels in
monochrome). In the absence of CDK11
p58, Plk4 signal is strongly reduced at the centrosome of mitotic cells. For each cell, one of the two
centrosomal regions is enlarged on the left panel. Bar is 5mm. B) Single section of a control or CDK11 siRNA treated cell stained for centrin (green) and
Plk4 (red). The insets show a 56magnification of the spindle pole region that contains 2 centrioles. See the strong reduction of the Plk4 signal in the
CDK11–depleted cell compared to the wild-type cell. Bar is 5mm. C) Graph showing the significant difference (p,0,0005) of Plk4 signal intensity (6SD)
per mitotic centriole in control (blue) or CDK11 siRNA (red) transfected cells. D) Control (top) or CDK11 (bottom) siRNAs-transfected HeLa interphase
cells stained for Plk4 (red), centrin (green). The right panels show a 36magnification of the centrosomal region. Bar is 10mm. E) Graph showing the
Plk4 signal (6SD) intensity per interphase centriole in control (blue) or CDK11 siRNA transfected cells (red). F) Analysis of exogenous Plk4 protein
levels in CDK11 knock down cells. Myc-Plk4-CD (Catalytic Domain; amin-acids 1–638, left panels) and Myc-Plk4-FL (Full Length; amino-acids 1–970,
right panels) expressing constructs were co-transfected with control or CDK11 siRNAs and the CDK11
p58 (bottom panels) and Myc-Plk4 (middle
panels) proteins levels were analysed by Western blotting 48 h following transfection. The membrane was stained by Ponceau S (top panels). In four
different experiments, exogenous Plk4 proteins are hardly detectable after 48h hours in control cells whereas they are more stable following CDK11
RNAi.
doi:10.1371/journal.pone.0014600.g003
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p58 can interact in vitro and in vivo. A) Scheme of the different Plk4 constructs used for the co-transfection and
immunoprecipitation experiments. Myc-Plk4-FL: Myc-tagged Plk4 full length; Myc-Plk4-NT: Myc-tagged Plk4 N-terminus domain; Myc-Plk4-CT: Myc-
tagged Plk4 C-terminus domain. The catalytic domain (CD) is displayed in red, the polo box (PB) in green and the phosphodegron (PD) in yellow. B)
GFP or GFP-CDK11
p58 were co-transfected with Myc-Plk4 in COS7 cells and the proteins were immunoprecipitated using GFP (left) or Myc antibodies
(right). Myc-Plk4 was co-immunoprecipitated with GFP-CDK11
p58 but not with GFP (left). GFP-CDK11
p58 (but not GFP) was also found in the Myc-Plk4
immunoprecipitates (right). C) Myc-Plk4-FL, Myc-Plk4-NT, Myc-Plk4-CT were co-transfected with GFP and/or GFP-CDK11
p58 in COS7 cells. Myc-tagged
Plk4 proteins were immunoprecipitated and revealed by Myc (top)(bottom). GFP-CDK11
p58 is detected in Myc-Plk4-FL and NT immunoprecipitates
whereas it is absent from Myc-Plk4-CT pull down (bottom). HC: immunoglobulin heavy chains; LC: immunoglobulin low chains. D) Maltose Binding
proteins (MBP) or MBP-CDK11
p58 proteins were immobilised on amylose beads and incubated with recombinant Plk4-V5-(His)6. After washes, the
Centrosome Biogenesis
PLoS ONE | www.plosone.org 8 January 2011 | Volume 6 | Issue 1 | e14600terminal fragment of the protein (Figure 4 A). Plk4 itself but
possibly other kinases are required for phosphorylation of this
important motif [33]. This phosphorylation of the phosphodegron
is crucial to allow the binding of SCF
Slimb and in turn for the
degradation of the protein because defective Plk4 degradation
triggers Plk4 stabilisation and centriole amplification
[13,14,33,34]. We first hypothesised that Plk4 was a substrate of
CDK11
p58 on this phosphodegron motif. Indeed, we found
elevated levels of exogenous tagged-Plk4 proteins following
CDK11
p58 depletion reflecting a possible stabilisation of endog-
enous Plk4 following CDK11 RNAi. However, the global effect
following CDK11 RNAi was a centriole duplication defect and not
an over duplication as expected in case of Plk4 overexpression. In
addition, centrioles from CDK11-depleted cells were not able to
over duplicate even if forced Plk4 overexpression was induced.
This result suggests that, in CDK11-depleted cells, the centrioles
lacked essential mitotic modifications allowing their subsequent
duplication in S phase (Figure S5). To conclude, if Plk4 does play a
role during mitosis, this possible Plk4 mitotic function cannot be
compensated by elevation of Plk4 protein levels during interphase
after CDK11 depletion.
To date, CDK11
p58 was suggested to play key roles at various
stages of the cell division, during centrosome maturation,
chromatid cohesion, and cytokinesis. Our data show for the first
time a new role for CDK11
p58 during centriole duplication,
probably mediated to some extent by the centrosomal direct or
indirect recruitment of Plk1 and Plk4 protein kinases at
centrosomes during mitosis. The emerging dual function of the
Cep192, Plk1 and CDK11
p58 proteins during centrosome
maturation and centriole duplication suggests that these two
mechanisms and the machinery involved in these processes are
closely connected [8,26,28]. Further studies will be required to
understand the mechanism of action of CDK11
p58 to potentially
validate key centrosomal proteins as substrates of this protein
kinase.
Materials and Methods
Plasmid and constructs
CDK11
p58 and CDK11
p58N were amplified by PCR using the
oligonucleotides
59TAGAATTCCCAGTGAAGATGAAGAACG
39
and
59TAGGATCCCCAGTGAAGATGAAGAACG
39 and sub-
cloned into the EcoRI and BamH1 sites of the COM263
pcDNA3.1/3xmycA/TO vector (kind gift of Pr Erich Nigg,
University of Basel). Myc-tagged expression constructs were
described before and were kindly given to us by Erich Nigg [11].
Plk4 protein was cloned into the pET102 plasmid following the
manufacturer instructions (Invitrogen) by PCR using the oligonucle-
otides
59CACCATGGCGACCTGCATCGGGGAG
39 and
59AT-
GAAAATTAGGAGTCGGATTAGA
39 to generate the pET102-
Plk4-V5-(His)6 expression vector. pCMV-GFP-CDK11
p58 was
described before [24].
Cell culture, transfections, siRNA-mediated protein
depletion and chemicals
The HeLa, HeLa TRex, and COS-7 cell lines were grown at
37uC in DMEM containing 10% FCS and 100U/ml of
streptomycin and penicillin (Invitrogen). The U2OS TRex cell
line was grown in DMEM containing 10% tetracycline negative
FCS (PAA, A15-109), supplemented with 50mg/ml Hygromycine
B (Invitrogen, 10687-010). Tetracycline inducible cell lines
expressing Myc-tagged wild type CDK11
p58 was generated by
transfection of U2OS-TRex cells kindly given to us by Pr Erich
Nigg [11]. Stable transformants were established by selection for
two weeks with 1mg/ml G418 (Invitrogen) and 50mg/ml
Hygromycin B. The HeLa cell line carrying a GFP-tagged centrin
was cultured in DMEM containing 10% FCS, 100UI/ml of
streptomycin and penicillin and 500mg/ml G418 [27]. DNA
transfections were performed using Lipofectamine 2000 following
the manufacturer instructions (Invitrogen). CDK11 and Plk4
proteins were depleted as already described [11,35]. For control
RNAi, a luciferase siRNA was used (Eurogentec). Cells were
arrested in S-phase using aphidicolin (4mg/ml) from Nigrospora
sphaerica (Sigma, A0781).
Antibodies
The following antibodies were used in this study: mouse anti-
GFP (0,4mg/ml, Roche), mouse anti-myc (clone 9E10, dilution
1mg/ml, Invitrogen), rabbit anti-centrin antibody (dilution 1/1000,
Abcam), rabbit anti-pericentrin (dilution 1/10 000, Abcam),
mouse anti-c-tubulin (dilution 1/1000, clone GTU-488, Sigma),
rat anti-tubulin (clone YL
1/2, dilution 1/1000, Millipore), rabbit
anti-Cep192 (dilution 1/500, kind gift of Laurence Pelletier,
Toronto, Canada), affinity-purified rabbit anti-Plk4 and affinity–
purified rabbit anti-CDK11 antibodies [11,21,24]. All secondary
antibodies used in immunofluorescence microscopy were from
Molecular Probes, and the peroxidase-coupled secondary anti-
bodies used for Western blotting were from Jackson Immunor-
esearch Laboratories.
Centrosome and centriole countings in fixed cells
Centriole countings in mitotic HeLa cells were performed using
a cell line carrying a GFP-centrin transgene. Centrioles were
obviously visible as 2 dots at each pole of mitotic control cells. In
U2OS interphase cells, centrosomes and centrioles were counted
in the cells after g tubulin and/or centrin staining respectively,
following a method described previously [6]. Each experiment was
repeated 3 times and .100 cells were scored by experiment.
Immunoprecipitations
5.10
6 cells expressing the tagged constructs were lysed into Lysis
Buffer (LB: 50mM HEPES, 100mM KCl, 1mM MgCl2, 1mM
EGTA, 0,5% NP40, 1mM b mercapto-ethanol, 20mM b
glycerophosphate, anti-protease inhibitor cocktail (Roche)). The
cell extracts were centrifuged for 10min at 10 000g and the soluble
proteins were incubated with 5mg of anti-GFP or anti-Myc
antibodies adsorbed on 50ml of magnetic Dynabeads protein A
beads (Invitrogen) for 3 hours. The immunoprecipitated proteins
were washed 3 times in LB during 5min. The proteins were
subjected to SDS polyacrylamide gel electrophoresis (SDS-PAGE),
followed by Western blotting analysis.
Kinase assays
For Plk4 kinase assays, 100ng of GST-Plk4 (Ozyme) was
incubated with b casein or Maltose Binding Protein (MBP) or
MBP-tagged CDK11
p58 [24] in kinase buffer (20mM Tris/HCl,
10mM MgCl2, 25mM NaCl) containing 100mM ATP and 1mCi of
beads (and bound proteins) were boiled in Laemmli buffer and the proteins were analysed following EGPA-SDS by Ponceau S staining to visualise
MBP and MBP-CDK11
p58 (left). The membrane was then probed by anti-V5 antibody to reveal the bound Plk4 recombinant protein. The input (1/25th)
is also shown on the gel. Thus, Plk4 and CDK11
p58 can bind directly to each other.
doi:10.1371/journal.pone.0014600.g004
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PLoS ONE | www.plosone.org 9 January 2011 | Volume 6 | Issue 1 | e14600Figure 5. CDK11-depleted cells cannot amplify their centrioles following Plk4 overexpression. A) Control or CDK11-depleted cells were
transfected with Myc-Plk4 construct and their ability to amplify their centrioles was analysed after S phase arrest. B) Example of a control siRNA
treated cell (left) over expressing Plk4 (red). See the presence of additional centrin (green) dots around each mother centriole. By contrast, most of
Myc-Plk4 over expressing cells can not amplify their centrioles following CDK11 siRNA transfection although the over expressed Plk4 protein kinase is
strongly recruited to the centriolar region.The insets shows a 56 magnification of the centrosomal region (centrin staining in displayed in
monochrome). Bar is 10mm.
doi:10.1371/journal.pone.0014600.g005
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15min at 25uC, stopped by addition of one volume of 26Laemmli
buffer and boiled 2min. The samples were analysed by SDS-
PAGE. The gels were stained by Coomassie dye, dried, and the
phosphorylated proteins were revealed using a Phosphoimager
(Molecular Dynamics).
Immunofluorescence
HeLa and U2OS cells grown on coverslips were fixed in
methanol at -20uC and processed for immunofluorescence
following standard protocols (Montembault et al., 2007). Cell
preparations were visualised with a Leica DMRXA2 microscope
(objective 636, N.A. 1,32). Measurements of fluorescence
intensities and image acquisition were performed using a CooSnap
ES camera with Metamorph software (Roper Scientific), and
pictures were prepared as single sections or maximum intensity
projections. Alternatively, slides were viewed with a Leica
DMIRE2 (SP2) inverted confocal microscope (objective 636,
N.A. 1,4) using the LCS 3D software (Leica). Images were
processed with Adobe Photoshop (v7.0).
Purification of recombinant proteins
MPB and MBP-CDK11
P58 protein immobilisation on amylose
column (Biolabs) was described before [35]. Plk4-V5-(His)6
expression was induced in E. coli for 4 hours at 25uC and the
recombinant protein was purified following standard procedures
[36] using Ni-NTA agarose beads (Quiagen). The Plk4-V5-(His)6
protein was stored at 220uC in 50% glycerol before using for the
in vitro MBP-CDK11
P58 binding assay.
In vitro binding assay
10mg ofMaltose Binding Protein (MBP) orMPB-CDK11
p58were
immobilised on amylose column (stored at 4uC in column buffer:
20mM Tris-HCL pH 7,4; 200mM NaCl; 1mM EDTA and 1mM
Sodium Azide) and incubated with 5mg of purified Plk4-V5-(His)6
protein kinase in binding buffer (PBS; 0,1% triton X-100 and 0,1%
NP40) for 1h at 4uC. After 3 washes for 5min at 4uC with 1 ml of
bindingbuffer,thebeadscontentwastheneluted byLaemmlibuffer
and the samples were analysed by anti-V5 Western blot.
Supporting Information
Figure S1 Localisation of Myc-tagged CDK11p58 in HeLa
cells. A) HeLa stable cell line was induced to express Myc-
CDK11
p58 for approximately 2 hours, fixed and stained for a-
tubulin (red in the left panels and monochrome in the middle
panels) and Myc (green in the left panels and monochrome in the
right panels). DNA is blue. Each phase of the cell cycle is indicated
at the top of each panel. During interphase (top panels), CDK11
remained cytoplasmic and started to accumulate on the astral
microtubules during prophase. The tagged protein remained
associated with spindle microtubules throughout the duration of
cell division. During cytokinesis a pool of the protein was found at
the midbody. The mitotic phases are displayed on the merge
panels. Scale bar is 10 mm. B) Interphase HeLa cell expressing
Myc-CDK11
p58. The lower panels show a 10 times magnification
of the centrosomal region. C) Mitotic HeLa cell expressing Myc-
CDK11
p58. The lower panels show a 5 times enlargement of one
of the spindle pole region. In panels B and C, Myc-CDK11
p58 is
green and monochrome in the right panel; pericentrin is red and
monochrome in the middle panel; and DNA is blue. Scale bars are
10 mm. See the complete absence of Myc signal at the centrosome
in interphase cell and the moderate signal at the spindle pole
region in mitotic cells.
Found at: doi:10.1371/journal.pone.0014600.s001 (4.43 MB TIF)
Figure S2 CDK11
p58 depletion interferes with centrosome
overduplication in S phase-arrested U2OS cells. A) U2OS cells
were transfected with control, Plk4,o rCDK11 siRNAs. 24 hours
post-transfection (duration of one cell cycle), the cells were treated
with aphidicolin for 48 hours to be arrested in S phase. Cells were
then fixed and the centrosomes were counted. B) The top panel
shows an S phase-arrested cell with more than two centrosomes
(white arrowhead). The bottom panel shows a cell with two
centrosomes (white arrowhead). DNA is blue and c tubulin, as a
centrosomal marker, is red and also displayed in monochrome on
the right panels. Scale bar is 10mm. C) Graph (6SD) showing the
percentage of cells with more than two centrosomes, the siRNA
treatment is indicated at the bottom. Note the 3-fold decrease of
centriole overduplication following Plk4 and CDK11 RNAi.
Found at: doi:10.1371/journal.pone.0014600.s002 (0.70 MB TIF)
Figure S3 The centrosomal recruitment of Cep192 in mitosis is
compromised in CDK11-depleted cells. A) Control (top) or CDK11
siRNA-transfected (middle and lower panels) mitotic cells were
fixed and stained for DNA (blue), a tubulin (red) and Cep192
(green and right panels in monochrome). Scale bar is 10 mm. B)
Graph showing Cep192 signal intensity (6SD) at the mitotic
centrosomes of control (green) and CDK11-depleted cells (red).
Found at: doi:10.1371/journal.pone.0014600.s003 (1.05 MB TIF)
Figure S4 CDK11
p58 is not a Plk4 substrate in vitro. b casein,
Maltose binding protein (MBP) and MBP-CDK11
p58 were
incubated without (lanes 2, 3 and 4 respectively) or with active
GST-PLK4 (lanes 5, 6 and 7 respectively) in the presence of
radiolabelled ATP. b casein is phosphorylated but not MBP or
MBP-CDK11
p58. The dark arrowheads indicate the positions of
the recombinant proteins. Auto-phosphorylation of GST-Plk4
(protein not visible by Coomassie staining) is detected on the
autoradiography (lanes 1, 5, 6 and 7) and is indicated by an arrow.
Found at: doi:10.1371/journal.pone.0014600.s004 (0.66 MB TIF)
Figure S5 Possible model of centriole duplication. Centriole
disengagement (licensing) is controlled by Plk1 and separase to
allow subsequent centriole duplication in interphase. Plk1 protein
kinase controls centrosome maturation during early mitosis (by
recruitment of PCM proteins including SPD-2/Cep192) and
centriole disengagement. Separase participates to this process in
late mitosis. Plk1 recruitment is under the control of CDK11
p58
protein kinase, which is only expressed during mitosis. Plk4 plays a
key role for centriole duplication during interphase and enhances
this process when overexpressed. Plk4 protein accumulation to the
mitotic centrosome, is controlled by CDK11
p58. Both proteins
interacts directly with each other indicating a possible involvement
of the Plk4 protein kinase during mitosis in the licensing process.
Found at: doi:10.1371/journal.pone.0014600.s005 (0.66 MB TIF)
Table S1 Analysis of mitotic figures following CDK11, Plk4, and
double RNAi in HeLa cells. The mitotic cells were fixed and
analysed for their mitotic spindle shape and their centriole
numbers (a scheme of each mitotic figure is displayed at the top
of each column). The percentage of each mitotic figure is indicated
(6SD).
Found at: doi:10.1371/journal.pone.0014600.s006 (0.05 MB
DOC)
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